Development and validation of an immunoluminometric assay (ilma) for fetuin-a-glycoprotein

Background: To identify dialysis patients with low fetuin-A levels, a sensitive immunoluminometric assay (ILMA) was developed. Methods: For the two-site ILMA, one monoclonal antibody was coated to polystyrene beads and one polyclonal antibody was labelled with acridinium ester. Results: The lower de...

Full description

Saved in:
Bibliographic Details
Main Authors: Bäumer, Amelie (Author) , Schmidt-Gayk, Heinrich (Author) , Aulmann, Michael (Author) , Kim, Ti-Sun (Author)
Format: Article (Journal)
Language:English
Published: 30 Dec 2009
In: Journal of immunoassay & immunochemistry
Year: 2009, Volume: 31, Issue: 1, Pages: 10-23
ISSN:1532-4230
DOI:10.1080/15321810903404830
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/15321810903404830
Get full text
Author Notes:Amelie Bäumer, Heinrich Schmidt-Gayk, Michael Aulmann, Ti-Sun Kim
Description
Summary:Background: To identify dialysis patients with low fetuin-A levels, a sensitive immunoluminometric assay (ILMA) was developed. Methods: For the two-site ILMA, one monoclonal antibody was coated to polystyrene beads and one polyclonal antibody was labelled with acridinium ester. Results: The lower detection threshold was 0.013 g/L, with the normal range 0.20-0.87 g/L (arithmetic mean 0.437 ± 0.118 g/L). Serum fetuin-A levels in the dialysis patients were significantly lower (arithmetic mean: 0.352 ± 0.099 g/L, p < 0.0001). Conclusion: This ILMA has been proved to be a reliable method for the determination of serum fetuin-A concentrations in dialysis patients.
Item Description:Gesehen am 30.11.2022
Physical Description:Online Resource
ISSN:1532-4230
DOI:10.1080/15321810903404830